Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee

Overview of attention for article published in Clinical Drug Investigation, August 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#30 of 1,035)
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

policy: 5 policy sources

patent: 6 patents

Citations

dimensions_citation: 197 Dimensions

Readers on

mendeley: 132 Mendeley

Summary Policy documents Patents Dimensions citations

So far, Altmetric has seen 6 patents that reference this research output.

Method of inhibiting chronification of pain

Grant US-10813891-B2

United States of America

TAPENTADOL FOR PREVENTING AND TREATING DEPRESSION AND ANXIETY

Application EP-3656380-A1

European Patent Office

Method of inhibiting chronification of pain

Grant US-10398657-B2

United States of America

Use of tapentadol for inhibiting and/or treating depression and anxiety

Grant US-9980927-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 2 additional patents.